Literature DB >> 16301494

Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease.

C A Maurage1, B Udd, M M Ruchoux, P Vermersch, H Kalimo, R Krahe, A Delacourte, N Sergeant.   

Abstract

Neurofibrillary degeneration (NFD) occurs in the brains of patients with myotonic dystrophy (DM) type 1. The authors report a similar tau pathology in the CNS of a patient with DM2 and compare it to that of patients with DM1. A reduced expression of tau exon 2 and exon 3 epitopes is observed in both DM1 and DM2. This suggests a similar physiopathologic process that may contribute to common neurologic features in patients with DM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301494     DOI: 10.1212/01.wnl.0000184585.93864.4e

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

Review 1.  RNA-binding proteins in microsatellite expansion disorders: mediators of RNA toxicity.

Authors:  Gloria V Echeverria; Thomas A Cooper
Journal:  Brain Res       Date:  2012-02-22       Impact factor: 3.252

2.  Case 12: my doctor says that I have ALS!

Authors:  Robin K Wilson; Vinay Chaudhry
Journal:  MedGenMed       Date:  2006-03-22

3.  Tau as a biomarker of neurodegenerative diseases.

Authors:  Susanna Schraen-Maschke; Nicolas Sergeant; Claire-Marie Dhaenens; Stéphanie Bombois; Vincent Deramecourt; Marie-Laure Caillet-Boudin; Florence Pasquier; Claude-Alain Maurage; Bernard Sablonnière; Eugeen Vanmechelen; Luc Buée
Journal:  Biomark Med       Date:  2008-08       Impact factor: 2.851

4.  High frequency of co-segregating CLCN1 mutations among myotonic dystrophy type 2 patients from Finland and Germany.

Authors:  T Suominen; B Schoser; O Raheem; S Auvinen; M Walter; R Krahe; H Lochmüller; W Kress; B Udd
Journal:  J Neurol       Date:  2008-09-24       Impact factor: 4.849

5.  APP(DeltaNL695) expression in murine tissue downregulates CNBP expression.

Authors:  Dana M Niedowicz; Tina L Beckett; Chris J Holler; Adam M Weidner; M Paul Murphy
Journal:  Neurosci Lett       Date:  2010-07-16       Impact factor: 3.046

Review 6.  The role of CELF proteins in neurological disorders.

Authors:  Jean-Marc Gallo; Carl Spickett
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

Review 7.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

8.  Bridging integrator 1 (BIN1) protein expression increases in the Alzheimer's disease brain and correlates with neurofibrillary tangle pathology.

Authors:  Christopher J Holler; Paulina R Davis; Tina L Beckett; Thomas L Platt; Robin L Webb; Elizabeth Head; M Paul Murphy
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

9.  Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.

Authors:  Stojan Peric; Gorana Mandic-Stojmenovic; Elka Stefanova; Dusanka Savic-Pavicevic; Jovan Pesovic; Vera Ilic; Valerija Dobricic; Ivana Basta; Dragana Lavrnic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2014-10-28       Impact factor: 4.849

10.  Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms.

Authors:  Benedikt Schoser; Lubov Timchenko
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.